第一个ATG101-招募小分子降解剂用于选择性CDK9降解通过自-溶酶体通路
Ye Zhong1, Jing Xu2,3, Huiying Cao3
1Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Acta pharmaceutica Sinica. B
|June 9, 2025
概括
研究人员开发了AZ-9,一种新型的选择性降解剂,用于循环素依赖性激酶9 (CDK9). 这种药物利用独特的自-溶解体通路来降解CDK9,比传统的抑制剂具有潜在的治疗优势.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 循环素依赖性激酶9 (CDK9) 对于转录调节至关重要.
- 选择性CDK9降解剂比可逆抑制剂具有临床优势.
研究的目的:
- 报告第一个ATG101-招募选择性CDK9降解剂,AZ-9.
- 研究AZ-9的降解机制和治疗潜力.
主要方法:
- 使用疏水性标记激素降解技术开发AZ-9.
- 在体外和体内评估AZ-9的降解效应和选择性.
- 探索涉及ATG101,LC3和自-溶酶体通路的分子机制.
主要成果:
- AZ-9显示显著的CDK9降解和对同源细胞周期CDK的选择性.
- AZ-9诱导了下游的表型变化.
- 该机制证实了ATG101的招募,LC3自细胞形成和CDK9和Cyclin T1.1的溶酶体降解.
结论:
- AZ-9代表了一种通过自-溶酶体通路向蛋白质降解的新策略.
- 这项研究验证了一种非蛋白质体降解途径,用于疏水驱动的蛋白质降解.
- 这些发现可能会激发对其他致病蛋白质的新化学干预.
相关概念视频
Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


